Krystal Biotech outlines $175M-$195M 2026 non-GAAP opex while targeting 6 data readouts before year-end (NASDAQ:KRYS)
Earnings Call Insights: Krystal Biotech (KRYS) Q1 2026 Management View "We delivered another quarter of global revenue growth with net ...
